Company / Cash & Equivalents
Tenet Health Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$2.9B
FY2025
5-year range
$858.0M / $3.0B
FY2021-FY2025
Trend
-4.5%
vs FY2024
Sector context
#17 of 148
Health Care
What the data says
Tenet Health's cash & equivalents of $2.9B is higher than 89% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $262M in FY2019 to $3.0B in FY2024.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +3.3%. Top quartile in the Health Care sector.
Improved from $1.2B to $2.9B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +49.8%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
+145.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.3%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 4.5% year-over-year.
- Ranks #17 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | -4.5% |
| FY2024 | $3.0B | +145.8% |
| FY2023 | $1.2B | +43.1% |
| FY2022 | $858.0M | -63.7% |
| FY2021 | $2.4B | -3.4% |
| FY2020 | $2.4B | +833.6% |
| FY2019 | $262.0M | -36.3% |
| FY2018 | $411.0M | -32.7% |
| FY2017 | $611.0M | -14.7% |
| FY2016 | $716.0M | +101.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026